Home › Funds › PERCEPTIVE ADVISORS LLC › IMVT
PERCEPTIVE ADVISORS LLC position in IMVT
IMMUNOVANT INC · Health Care
PERCEPTIVE ADVISORS LLC reported holding 1,357,383 shares of IMVT (IMMUNOVANT INC) in its Q2 2026 13F filing — a position valued at US$52.3M, representing 0.83% of its reported portfolio and ranking #28 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed IMVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PERCEPTIVE ADVISORS LLC's IMVT position evolved
PERCEPTIVE ADVISORS LLC first disclosed a stake in IMVT in Q3 2023 at 3,814,691 shares (US$146.4M). Across 12 filings, PERCEPTIVE ADVISORS LLC increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,357,383 shares valued at US$52.3M — a reduction of -240,000 shares quarter over quarter.. Notable position changes include a 96% trim in Q1 2024 (shares fell 18% over the following quarter), a 100% increase in Q2 2024 (shares rose 8% over the following quarter), a 1089% increase in Q3 2024 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.81M | $146.45M | New |
| Q4 2023 | 2.33M | $98.08M | Reduce |
| Q1 2024 | 100.00K | $3.23M | Reduce |
| Q2 2024 | 200.00K | $5.28M | Add |
| Q3 2024 | 2.38M | $67.82M | Add |
| Q4 2024 | 2.14M | $52.99M | Reduce |
| Q1 2025 | 2.84M | $48.61M | Add |
| Q2 2025 | 2.14M | $34.21M | Reduce |
| Q3 2025 | 1.59M | $25.60M | Reduce |
| Q4 2025 | 1.99M | $50.71M | Add |
| Q1 2026 | 1.60M | $39.68M | Reduce |
| Q2 2026 | 1.36M | $52.30M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMVT and 13F data
IMVT (IMMUNOVANT INC) is a Health Care company. 39 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMVT
- Deep Track Capital, LP 9.34M sh · $359.91M · Q2 2026
- Farallon Capital Management 5.80M sh · $223.67M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 5.80M sh · $223.67M · Q2 2026
- BAKER BROS. ADVISORS LP 5.44M sh · $209.42M · Q2 2026
- TCG Crossover Management, LLC 4.46M sh · $171.77M · Q2 2026
- Two Seas Capital LP 4.61M sh · $155.82M · Q3 2026
- RTW INVESTMENTS, LP 3.18M sh · $122.44M · Q2 2026
- ADAR1 Capital Management, LLC 2.33M sh · $89.80M · Q2 2026
- Alpine Global Management, LLC 1.38M sh · $52.98M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.20M sh · $46.24M · Q2 2026
- Logos Global Management LP 665.00K sh · $25.62M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 619.10K sh · $23.85M · Q2 2026
More on PERCEPTIVE ADVISORS LLC
FAQ
How long has PERCEPTIVE ADVISORS LLC held IMVT?
PERCEPTIVE ADVISORS LLC has disclosed IMVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is PERCEPTIVE ADVISORS LLC's current position in IMVT?
As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 1.36M shares of IMVT (IMMUNOVANT INC), valued at $52.30M, representing 0.83% of its reported portfolio and ranking #28.
Has PERCEPTIVE ADVISORS LLC been buying or selling IMVT?
In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC reduced its position in IMVT.
Which other funds hold IMVT?
Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.